Your browser doesn't support javascript.
loading
HLA-independent T cell receptors for targeting tumors with low antigen density.
Mansilla-Soto, Jorge; Eyquem, Justin; Haubner, Sascha; Hamieh, Mohamad; Feucht, Judith; Paillon, Noémie; Zucchetti, Andrés Ernesto; Li, Zhuoning; Sjöstrand, Maria; Lindenbergh, Pieter L; Saetersmoen, Michelle; Dobrin, Anton; Maurin, Mathieu; Iyer, Archana; Garcia Angus, Andreina; Miele, Matthew M; Zhao, Zeguo; Giavridis, Theodoros; van der Stegen, Sjoukje J C; Tamzalit, Fella; Rivière, Isabelle; Huse, Morgan; Hendrickson, Ronald C; Hivroz, Claire; Sadelain, Michel.
Afiliação
  • Mansilla-Soto J; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA. mansillj@mskcc.org.
  • Eyquem J; Immunology Program, Sloan Kettering Institute, New York, NY, USA. mansillj@mskcc.org.
  • Haubner S; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hamieh M; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Feucht J; Department of Medicine, Division of Hemato-Oncology, University of California San Francisco, San Francisco, CA, USA.
  • Paillon N; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zucchetti AE; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Li Z; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sjöstrand M; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Lindenbergh PL; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Saetersmoen M; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Dobrin A; Cluster of Excellence iFIT, University Children's Hospital Tübingen, Tübingen, Germany.
  • Maurin M; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France.
  • Iyer A; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France.
  • Garcia Angus A; Microchemistry and Proteomics Core Laboratory, Sloan Kettering Institute, New York, NY, USA.
  • Miele MM; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Zhao Z; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Giavridis T; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • van der Stegen SJC; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Tamzalit F; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Rivière I; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Huse M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Hendrickson RC; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hivroz C; Immunology Program, Sloan Kettering Institute, New York, NY, USA.
  • Sadelain M; Institute Curie, Université PSL, U932 INSERM, Integrative Analysis of T cell Activation Team, Paris, France.
Nat Med ; 28(2): 345-352, 2022 02.
Article em En | MEDLINE | ID: mdl-35027758
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Receptores de Antígenos Quiméricos Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article